SlideShare ist ein Scribd-Unternehmen logo
1 von 38
Fever in kids


François Gaumont, md
Antipasto

q   Ron Dagan       q   Rochester ,NY
q   Paul McCarhty   q   West Haven,Ct
q   Douglas Baker   q   Philadelphia, Pen
q   Baskin          q   Boston, Mass
q   Larry Baraff    q   Los Angeles,Ca
q   Nathan          q   Davis, Ca
    Kuppermann
History
q   1920-30; Recognition of potential serious
    bacterial infection in well looking febrile
    child. Dunham EC:Septicemia in the newborn, Am J Dis Child 1933;45;229-253
q   Age 8 weeks or less
q   Tº 38ºC rectal
q   Long standing controversies
             • What risks, who is/who is not, who looks sick/who
               doesn’t, who to keep/who to send, who to treat who
               not to.
q   No consistency
FEVER = 38º C
   rectal
Epidemiology of fever

q 10-20% of all ER visits
q 20% of fevers are FWS

q 1.6% of all ED visits, 3-36 Mo
  > 39°C, non-toxic
q Most common complaint < 6 Mo

q Most high fever are benign
Fever Phobia Revisited: Have
     Parental Misconceptions About
      Fever Changed in 20 Years?
            Pediatrics, Volume 107, Number 6, June 2001, Michael Crocetti   1
                                                                                MD




                  Harmful effects of fever
q   Type                       Schmitt (n = 81)               Crocetti et al (n =
    340 )
q   Seizure                               15%                 32%
q   Brain damage                          45%                 21%
q   Death                                 8%                  14%
q   Dehydration                           4%                  4%
q   Really sick                           1%                  2%
q   Coma                                  4%                  2%
q   Delirium                              12%                 1%
q   Blindness                             3%                  1%
q   No response                           6%                  9%
q   Other                                 -                   14%
q   Total                                 100%                100%
Clinical Thought
                  Process

                          FEVER


  S IC K                                      N O T S IC K


W O RK UP         F O C A L IN F E C T IO N                  N O F O C A L IN F E C T IO N
  A D M IT                                                           hx and PE


                     IN V E S T IG A T E              W H O W IL L G E T S IC K A N D W H A T
                          TR E AT
                          A D M IT
None of this applies to the sick looking child...

               That is assuming we know what a sick kid is?!
Relevant Age Groups
                and development




q 0………4w
q 0………………..8w

q 0……….……………….12w

q               12w………..3y
q > 3 years old



q   Age stratification of risk for SBI
LOW AND HIGH-RISK CRITERIA COMMONLY
       USED IN STUDIES OF FEVER WITHOUT
                    SOURCE


q   Low-risk Criteria                      High-risk Criteria
q   Term gestation (37 weeks)       Recurrent febrile illnesses
q   Uncomplicated prenatal course   Prematurity
q   No recent (7d) antibiotic       Congenital immune disease
q   No recent surgery               Sickle cell disease
q   No chronic illness              Asplenia
q   No perinatal ATB                Malignancy/chemotherapy
                                    Recent steroid therapy
q   Hospitalized = to mother        HIV disease
Yale Observation Scale
                   Score
       q   Quality of cry                         q   Score 6-10 well
       q   Alertness                              q   Score 11-15 mod
       q   Color                                  q   Score > 15 toxic
       q   Hydration
       q   Response to
           parents
       q   Response to
           others
McCarthy PL, Sharpe MR, Spiesel SZ, et al: Observation scales to identify serious illness in
febrile children. Pediatrics 1982; 70:802
Yale Observation Scale
            Score
                    q   OB
q   6-10    well    q   2,5%
q   11-15   mod     q   4,7%
q   > 15    toxic   q   5,7%
Patients               Patients
           with OB                without OB
                                                         Sens Spec PPV NPV

YOS No.                %          No.         %          %           %          %           %

>6         55          28.6 1122 17.5 28.6 82.5 4.7                                         97.4

>8         32          16.7 522               8.1        16.7 91.9 5.8                      97.3

>10 10                 5.2        210         3.3        5.2         96.7 4.5               97.1

>12 1                  0.5        75          1.2        0.5         98.8 1.3               97.1
Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of
age, treated as outpatients. Stephen J. Teach Journal of Pediatrics, Volume 126, Number 6, June 1995
Predictors of
                                   bacteremia
         q   History                                           q   WBC
         q   Physical exam                                     q   ANC
         q   Gender                                            q   Bands
         q   Height of fever                                   q   Band/Neutrophils
                                                                   ratio
                                                               q   PMN%
                                                               q   ESR-CRP-cytokines

Daniel Isaacman, Predictors of bacteremia in febrile children 3-36 Mo of age, Pediatrics;106;5;Nov 2000
                                                                         age

Nathan Kupperman, Predictors of occult bacteremia in young febrile children, Ann Emerg Med June 98;31;679-687
                                                                   children
Rochester Criterias for
           infants under 3 months
       q   Term                                    q   15 000 WBC
       q   Previously                              q   1500 bands
           healthy                                 q   5 WBC/hpf in
       q   Non-toxic                                   stool
       q   No focus                                q   10 WBC/hps in
       q   No previous ATB                             spun urine



Ron Dagan, Identification of infants unlikely to have serious bacterial infection although
hospitalized for suspected sepsis, J Pediatr 1985;107;855-860
Rochester Criterias for
           infants under 3 months


       q Risk of 0.5-1.1% for SBI including
         meningitis
       q NPV 98,5%




Jaskiewicz JA, McCarthy CA, Richardson AC, et al: Febrile infants at low risk for serious
bacterial infection-an appraisal of the Rochester criteria and implications for management.
Pediatrics 1994;94:390-396
Philadelphia Criterias

q   Non-toxic    q   WBC < 15 000
q   No focus     q   BNR < .2
q   No immuno-   q   U/A
    deficiency          • < 10 wbc/hpf
                          spun,
                        • -ve gram stain
                 q   CSF
                        • < 8 wbc
                        • -ve gramstain
                        • normal gluc, prot
                 q   CXR, if signs
“It has been well described
that a well appearing young
  infant may have an SBI…
    therefore, laboratory
investigation is necessary.”
1-Baraff LJ, Oslund S, Schriger DL, et al. Probability of bacterial infections in infants less
than three months of age: a meta-analysis. Pediatr Infect Dis J. 1992;11:257-265

2-Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious
illness in febrile 4 to 8 week old infants. Pediatrics. 1990;85:1040-1043

3-Larry J. Baraff Management of fever without source in infants and children
Annals of Emergency Medicine Volume 36 Number 6 December 2000
Clinical Thought
                  Process

                          FEVER


  S IC K                                      N O T S IC K


W O RK UP         F O C A L IN F E C T IO N                  N O F O C A L IN F E C T IO N
  A D M IT                                                           hx and PE


                     IN V E S T IG A T E              W H O W IL L G E T S IC K A N D W H A T
                          TR E AT
                          A D M IT
Predictors of
                            bacteremia


          qe                w
                                       / 1+e                                 w
          q   w = .1673x ANC + .2006x Tº + .
              8434x gender - 12.454



Isaacman J., Predictors of bacteremia in febrile children 3 to 36 months of age, Pediatrics Nov
2000;106;5,
Common bugs of OB

q S.pneumoniae              1-3%
q Salmonella non-thyphoïd   .1-.2%
q N.meningitidis            .025%
Management

q   Mood swings
q   ED waiting time
q   Gut feeling
q   Guidelines
q   Clinical policies
q   Decision analysis
q   Algorithm
q   Resolution of conflicts in Freud’s second
    stage of development
Clinical Guidelines in the Setting
       of Incomplete Evidence
                DAVID L. SCHRIGER ,Pediatrics, Volume 100 Number 1 July 1997




       q   “...the infectious disease experts who predominate
           the article by Baraff et al emphasize their
           experience with the rare child who does poorly;
           Kramer and Shapiro emphasize primary care
           practitioners' experience with the hundreds of
           children who do well…”

       q    “...while most academic pediatric researchers
           have approached the febrile child as if there is only
           one opportunity to make the correct diagnosis and
           initiate treatment…”


Kramer MS, Management of the febrile infant: a commentary on recent practice guidelines,
Pediatrics;100;1;July 1997
Clinical Policy for the Initial Approach to
Children Under the Age of 2 Years Presenting
                  with Fever
       Annals of Emergency Medicine Volume 22 Number 3 March 1993




   q   “...If the rules regarding admission
       appear too stringent at times, we
       remind our members that deviation
       from the rules requires only that the
       physician justify the deviation. In
       general, the rules are meant to
       protect the child…”
A survey about management of febrile
children without source by primary care
              physicians.
         Wittler RR - Pediatr Infect Dis J - 1998 Apr; 17(4): 271-7




  q   1600 mailing list
  q   GP, EP, Paeds
  q   3w, 7w, 4 mo, 16 mo, fever without
      source
  q   Strong agreement to admit 3w and
      7w
  q   Outpatient ATB for 4 mo
      • GP 28%, Paeds 45%, EP 59%
             ¢¯ x3À of ceftriaxone since ‘91
Pediatricians' Awareness of and
Attitudes About Four Clinical Practice
              Guidelines
           Pediatrics Volume 101 Number 5 May 1998




q   National survey, 300 respondants
    • 64% aware
How about no treatment
       for OB
q   Persistent fever
           • 76% Vs 24%
q   Persistent bacteremia
           • 17% Vs 1,6%
q   Admitted
           • 50% Vs 12%
q   Cellulitis
q   Pneumonia
q   Meningitis
           • 2.7%-5.8% Vs 0.4%
Serious bacterial
                            infection
         q   MENINGITIS
                           •   risk of OB 3% (85% pneumococcal)
                           •   risk of pneumococcal meningitis 3%
                           •   case fatality rate of 7,7%
                           •   25-30% neurologic sequelae




Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in
children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
Pediatrics. 1998;102:1087-1097.

Pikis A, Kavaliotis J, Tsikoulas J, et al. Long-term sequelae of pneumococcal meningitis in children. Clin Pediatr.
1996;35:72-78.
Treatment
q Antibiotics   ???    q Route   ???
 • Benzathine pen       • PO
 • amoxil               • IM
 • amoxil/clavulanic    • IV
   acid
 • ceftriaxone
Admission
           q    Is it safe? Reassuring?
           q    Iatrogenic and financial cost
                                 •   nosocomial infections
                                 •   iv infiltrates, fluid overload
                                 •   drug toxicity
                                 •   repeated testing, lost samples, contaminted
                                     samples, mislabeling
                                 • Stolen infant
           q    There is no such thing as a short admission
           q    Higher rates of admission if referred


Iatrogenic risks and financial costs of hospitalizing febrile infants, DeAngelis C., AM J Dis
Child;137;1146-1149;Dec 1983
Pneumococcal
                      vaccine
         q   Capsular polysaccharide, major virulence factor
         q   Conjugate, improved immunogenicity in young infants
         q   Pneumococcal proteins
                          • pneumolysin, pneumococcal surface
                            protein A and pneumococcal surface
                            adhesin A
         q   Decreases colonisation as well as
             invasive infection
         q   Replacement colonisation

Rubin L.G, Pneumococcal vaccine, Pediatric Clinics of North America
Volume 47 Number 2 April 2000
Pneumococcal vaccine

q   Efficacy
          • meningitis
          • invasive disease
          • pneumonia


q   Schedule at 2,4,6,12,15 months
Fever in the post-
                  S.pneumoniae era
       q 95% HI-b invasive decrease
         1987-1994
       q Median age for bacterial
         meningitis
                           • 1986 - 15 months
                           • 1995 - 25 years




Anne Schuchat, Bacterial meningitis in the US in 1995, N Engl J Med1997;337;970-6
Who will you go with?

q   Ron Dagan       q   Rochester ,NY
q   Paul McCarhty   q   New Haven, Ct
q   Douglas Baker   q   Philadelphia, Pen
q   Baskin          q   Boston, Mass
q   Larry Baraff    q   Los Angeles,Ca
q   Nathan          q   Davis, Ca
    Kuppermann
CONCLUSION

q   Adopt one line of conduct
q   Primum non-nocere
q   Elevate yourself beyond statistical
    numbers
q   Clinical judgment, medical common sens
    and decision making is what we trained for
Definitions

q   Fever without a source (FWS)
    • No apparent etiology from history and
      physical examination
q   Fever of unknown origin (FUO)
    • No apparent etiology from history and
      physical examination lasting for at least
      14 days
q   Serious bacterial infection (SBI)
    • Meningitis, bacteremia, pneumonia, uti,
      otitis,cellulitis,osteomyelitis
Definitions

q   Occult bacteremia
    • presence of pathogenic bacterial
      organism in blood cultures of child
      with suspected infection

Weitere ähnliche Inhalte

Was ist angesagt?

Subgaleal Hemorrhage - Dr Padmesh - Neonatology
Subgaleal Hemorrhage - Dr Padmesh - NeonatologySubgaleal Hemorrhage - Dr Padmesh - Neonatology
Subgaleal Hemorrhage - Dr Padmesh - NeonatologyDr Padmesh Vadakepat
 
Seizure disorders in children
Seizure disorders in childrenSeizure disorders in children
Seizure disorders in childrenMalith Niluka
 
Dengue in Children
Dengue in ChildrenDengue in Children
Dengue in ChildrenCSN Vittal
 
Burns in pediatrics presentation
Burns in pediatrics presentationBurns in pediatrics presentation
Burns in pediatrics presentationElla Olevson Dayan
 
An approach to a child with fever
An approach to a child with feverAn approach to a child with fever
An approach to a child with feverTarek Kotb
 
Common skin conditions in neonates
Common skin conditions in neonatesCommon skin conditions in neonates
Common skin conditions in neonatesKezha Zutso
 
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...Prof Dr Bashir Ahmed Dar
 
Fever in children by dr Hussein Abdeldayem
Fever in children by dr Hussein AbdeldayemFever in children by dr Hussein Abdeldayem
Fever in children by dr Hussein AbdeldayemHussein Abdeldayem
 
Chronic bacterial & viral meningoencephalitis (2)
Chronic bacterial & viral meningoencephalitis (2)Chronic bacterial & viral meningoencephalitis (2)
Chronic bacterial & viral meningoencephalitis (2)Mohammad Manzoor
 
Dengue in emergency department
Dengue in emergency departmentDengue in emergency department
Dengue in emergency departmentdayangrafidah
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTarek Kotb
 

Was ist angesagt? (20)

Neonatal resuscitation programme, NRP
Neonatal  resuscitation programme, NRPNeonatal  resuscitation programme, NRP
Neonatal resuscitation programme, NRP
 
Pain management in neonates
Pain management in neonatesPain management in neonates
Pain management in neonates
 
Subgaleal Hemorrhage - Dr Padmesh - Neonatology
Subgaleal Hemorrhage - Dr Padmesh - NeonatologySubgaleal Hemorrhage - Dr Padmesh - Neonatology
Subgaleal Hemorrhage - Dr Padmesh - Neonatology
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 
Seizure disorders in children
Seizure disorders in childrenSeizure disorders in children
Seizure disorders in children
 
Umbilical Venous Catheter
Umbilical Venous CatheterUmbilical Venous Catheter
Umbilical Venous Catheter
 
02NTD 2022 - Approach to Severe Dengue
02NTD 2022 - Approach to Severe Dengue02NTD 2022 - Approach to Severe Dengue
02NTD 2022 - Approach to Severe Dengue
 
Dengue in Children
Dengue in ChildrenDengue in Children
Dengue in Children
 
Burns in pediatrics presentation
Burns in pediatrics presentationBurns in pediatrics presentation
Burns in pediatrics presentation
 
An approach to a child with fever
An approach to a child with feverAn approach to a child with fever
An approach to a child with fever
 
OSCE Pediatrics KKCTH
OSCE Pediatrics KKCTHOSCE Pediatrics KKCTH
OSCE Pediatrics KKCTH
 
Febrile seizures
Febrile seizuresFebrile seizures
Febrile seizures
 
Common skin conditions in neonates
Common skin conditions in neonatesCommon skin conditions in neonates
Common skin conditions in neonates
 
Neonatal sepsis management
Neonatal sepsis managementNeonatal sepsis management
Neonatal sepsis management
 
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...
BACTERIAL MENINGITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE CHIN...
 
Fever in children by dr Hussein Abdeldayem
Fever in children by dr Hussein AbdeldayemFever in children by dr Hussein Abdeldayem
Fever in children by dr Hussein Abdeldayem
 
Chronic bacterial & viral meningoencephalitis (2)
Chronic bacterial & viral meningoencephalitis (2)Chronic bacterial & viral meningoencephalitis (2)
Chronic bacterial & viral meningoencephalitis (2)
 
Febrile seizures
Febrile seizuresFebrile seizures
Febrile seizures
 
Dengue in emergency department
Dengue in emergency departmentDengue in emergency department
Dengue in emergency department
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttn
 

Andere mochten auch (7)

Fever for 3rd year.
Fever for 3rd year.Fever for 3rd year.
Fever for 3rd year.
 
Pyrexia
PyrexiaPyrexia
Pyrexia
 
Fever
FeverFever
Fever
 
Fever
FeverFever
Fever
 
Approach to history taking in a patient with fever
Approach  to  history  taking  in  a  patient  with  feverApproach  to  history  taking  in  a  patient  with  fever
Approach to history taking in a patient with fever
 
Fever lecture note
Fever lecture noteFever lecture note
Fever lecture note
 
Fever
FeverFever
Fever
 

Ähnlich wie Fever in Kids: Causes, Risks & Treatment

Congenital syphilis arire
Congenital syphilis arireCongenital syphilis arire
Congenital syphilis arireYves Kanubana
 
The Febrile Neonate and Young Infant: An Evidence Based Review
The Febrile Neonate and Young Infant: An Evidence Based ReviewThe Febrile Neonate and Young Infant: An Evidence Based Review
The Febrile Neonate and Young Infant: An Evidence Based Reviewdpark419
 
Neonatal sepsis surenda godara 23-8-11
Neonatal sepsis surenda godara 23-8-11Neonatal sepsis surenda godara 23-8-11
Neonatal sepsis surenda godara 23-8-11Surendra Godara
 
Evaluating Pediatric Fever
Evaluating Pediatric FeverEvaluating Pediatric Fever
Evaluating Pediatric FeverSondraBaumcratz
 
Fever without a source in Pediatrics
Fever without a source in PediatricsFever without a source in Pediatrics
Fever without a source in PediatricsMedPeds Hospitalist
 
pap-smear-interpretation.pptx
pap-smear-interpretation.pptxpap-smear-interpretation.pptx
pap-smear-interpretation.pptxMeshalAlobaid3
 
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...Anil Gupta
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganHendrik Sutopo
 
259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt
259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt
259921702-Top-10-Nephro-Slides-in-Board-Exams.pptRajivKabad
 
Patent Ductus Arteriosus - news and views on diagnosis and management
Patent Ductus Arteriosus - news and views on diagnosis and managementPatent Ductus Arteriosus - news and views on diagnosis and management
Patent Ductus Arteriosus - news and views on diagnosis and managementStefan Johansson
 
Outcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsOutcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsescts2012
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainPuneet Jain
 
Pulmonary embolism and lung scans
Pulmonary embolism and lung scansPulmonary embolism and lung scans
Pulmonary embolism and lung scansdriainduncan
 

Ähnlich wie Fever in Kids: Causes, Risks & Treatment (20)

Congenital syphilis arire
Congenital syphilis arireCongenital syphilis arire
Congenital syphilis arire
 
The Febrile Neonate and Young Infant: An Evidence Based Review
The Febrile Neonate and Young Infant: An Evidence Based ReviewThe Febrile Neonate and Young Infant: An Evidence Based Review
The Febrile Neonate and Young Infant: An Evidence Based Review
 
Neonatal sepsis surenda godara 23-8-11
Neonatal sepsis surenda godara 23-8-11Neonatal sepsis surenda godara 23-8-11
Neonatal sepsis surenda godara 23-8-11
 
Evaluating Pediatric Fever
Evaluating Pediatric FeverEvaluating Pediatric Fever
Evaluating Pediatric Fever
 
Fever without a source in Pediatrics
Fever without a source in PediatricsFever without a source in Pediatrics
Fever without a source in Pediatrics
 
Appendicitis
AppendicitisAppendicitis
Appendicitis
 
pap-smear-interpretation.pptx
pap-smear-interpretation.pptxpap-smear-interpretation.pptx
pap-smear-interpretation.pptx
 
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...
Review of Early Infant Diagnosis of HIV-1 in Delhi by Dr.A.K. Gupta, Addition...
 
Cd Mortality
Cd MortalityCd Mortality
Cd Mortality
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
 
Febrile child
Febrile childFebrile child
Febrile child
 
259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt
259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt
259921702-Top-10-Nephro-Slides-in-Board-Exams.ppt
 
Patent Ductus Arteriosus - news and views on diagnosis and management
Patent Ductus Arteriosus - news and views on diagnosis and managementPatent Ductus Arteriosus - news and views on diagnosis and management
Patent Ductus Arteriosus - news and views on diagnosis and management
 
Neonatal sepsis Ramadan A Mahmoud
Neonatal sepsis Ramadan A MahmoudNeonatal sepsis Ramadan A Mahmoud
Neonatal sepsis Ramadan A Mahmoud
 
Outcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsOutcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patients
 
0406 marmorfws
0406 marmorfws0406 marmorfws
0406 marmorfws
 
Sepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet JainSepsis biomarkers an update by Dr Puneet Jain
Sepsis biomarkers an update by Dr Puneet Jain
 
Pulmonary embolism and lung scans
Pulmonary embolism and lung scansPulmonary embolism and lung scans
Pulmonary embolism and lung scans
 
Congenitalsyphilis
CongenitalsyphilisCongenitalsyphilis
Congenitalsyphilis
 
Std noon conf 2019
Std  noon conf 2019Std  noon conf 2019
Std noon conf 2019
 

Kürzlich hochgeladen

SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 

Kürzlich hochgeladen (20)

SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 

Fever in Kids: Causes, Risks & Treatment

  • 2. Antipasto q Ron Dagan q Rochester ,NY q Paul McCarhty q West Haven,Ct q Douglas Baker q Philadelphia, Pen q Baskin q Boston, Mass q Larry Baraff q Los Angeles,Ca q Nathan q Davis, Ca Kuppermann
  • 3. History q 1920-30; Recognition of potential serious bacterial infection in well looking febrile child. Dunham EC:Septicemia in the newborn, Am J Dis Child 1933;45;229-253 q Age 8 weeks or less q Tº 38ºC rectal q Long standing controversies • What risks, who is/who is not, who looks sick/who doesn’t, who to keep/who to send, who to treat who not to. q No consistency
  • 4. FEVER = 38º C rectal
  • 5.
  • 6. Epidemiology of fever q 10-20% of all ER visits q 20% of fevers are FWS q 1.6% of all ED visits, 3-36 Mo > 39°C, non-toxic q Most common complaint < 6 Mo q Most high fever are benign
  • 7. Fever Phobia Revisited: Have Parental Misconceptions About Fever Changed in 20 Years? Pediatrics, Volume 107, Number 6, June 2001, Michael Crocetti 1 MD Harmful effects of fever q Type Schmitt (n = 81) Crocetti et al (n = 340 ) q Seizure 15% 32% q Brain damage 45% 21% q Death 8% 14% q Dehydration 4% 4% q Really sick 1% 2% q Coma 4% 2% q Delirium 12% 1% q Blindness 3% 1% q No response 6% 9% q Other - 14% q Total 100% 100%
  • 8. Clinical Thought Process FEVER S IC K N O T S IC K W O RK UP F O C A L IN F E C T IO N N O F O C A L IN F E C T IO N A D M IT hx and PE IN V E S T IG A T E W H O W IL L G E T S IC K A N D W H A T TR E AT A D M IT
  • 9. None of this applies to the sick looking child... That is assuming we know what a sick kid is?!
  • 10. Relevant Age Groups and development q 0………4w q 0………………..8w q 0……….……………….12w q 12w………..3y q > 3 years old q Age stratification of risk for SBI
  • 11. LOW AND HIGH-RISK CRITERIA COMMONLY USED IN STUDIES OF FEVER WITHOUT SOURCE q Low-risk Criteria High-risk Criteria q Term gestation (37 weeks) Recurrent febrile illnesses q Uncomplicated prenatal course Prematurity q No recent (7d) antibiotic Congenital immune disease q No recent surgery Sickle cell disease q No chronic illness Asplenia q No perinatal ATB Malignancy/chemotherapy Recent steroid therapy q Hospitalized = to mother HIV disease
  • 12. Yale Observation Scale Score q Quality of cry q Score 6-10 well q Alertness q Score 11-15 mod q Color q Score > 15 toxic q Hydration q Response to parents q Response to others McCarthy PL, Sharpe MR, Spiesel SZ, et al: Observation scales to identify serious illness in febrile children. Pediatrics 1982; 70:802
  • 13. Yale Observation Scale Score q OB q 6-10 well q 2,5% q 11-15 mod q 4,7% q > 15 toxic q 5,7%
  • 14. Patients Patients with OB without OB Sens Spec PPV NPV YOS No. % No. % % % % % >6 55 28.6 1122 17.5 28.6 82.5 4.7 97.4 >8 32 16.7 522 8.1 16.7 91.9 5.8 97.3 >10 10 5.2 210 3.3 5.2 96.7 4.5 97.1 >12 1 0.5 75 1.2 0.5 98.8 1.3 97.1 Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of age, treated as outpatients. Stephen J. Teach Journal of Pediatrics, Volume 126, Number 6, June 1995
  • 15. Predictors of bacteremia q History q WBC q Physical exam q ANC q Gender q Bands q Height of fever q Band/Neutrophils ratio q PMN% q ESR-CRP-cytokines Daniel Isaacman, Predictors of bacteremia in febrile children 3-36 Mo of age, Pediatrics;106;5;Nov 2000 age Nathan Kupperman, Predictors of occult bacteremia in young febrile children, Ann Emerg Med June 98;31;679-687 children
  • 16. Rochester Criterias for infants under 3 months q Term q 15 000 WBC q Previously q 1500 bands healthy q 5 WBC/hpf in q Non-toxic stool q No focus q 10 WBC/hps in q No previous ATB spun urine Ron Dagan, Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis, J Pediatr 1985;107;855-860
  • 17. Rochester Criterias for infants under 3 months q Risk of 0.5-1.1% for SBI including meningitis q NPV 98,5% Jaskiewicz JA, McCarthy CA, Richardson AC, et al: Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Pediatrics 1994;94:390-396
  • 18. Philadelphia Criterias q Non-toxic q WBC < 15 000 q No focus q BNR < .2 q No immuno- q U/A deficiency • < 10 wbc/hpf spun, • -ve gram stain q CSF • < 8 wbc • -ve gramstain • normal gluc, prot q CXR, if signs
  • 19. “It has been well described that a well appearing young infant may have an SBI… therefore, laboratory investigation is necessary.” 1-Baraff LJ, Oslund S, Schriger DL, et al. Probability of bacterial infections in infants less than three months of age: a meta-analysis. Pediatr Infect Dis J. 1992;11:257-265 2-Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile 4 to 8 week old infants. Pediatrics. 1990;85:1040-1043 3-Larry J. Baraff Management of fever without source in infants and children Annals of Emergency Medicine Volume 36 Number 6 December 2000
  • 20. Clinical Thought Process FEVER S IC K N O T S IC K W O RK UP F O C A L IN F E C T IO N N O F O C A L IN F E C T IO N A D M IT hx and PE IN V E S T IG A T E W H O W IL L G E T S IC K A N D W H A T TR E AT A D M IT
  • 21. Predictors of bacteremia qe w / 1+e w q w = .1673x ANC + .2006x Tº + . 8434x gender - 12.454 Isaacman J., Predictors of bacteremia in febrile children 3 to 36 months of age, Pediatrics Nov 2000;106;5,
  • 22. Common bugs of OB q S.pneumoniae 1-3% q Salmonella non-thyphoïd .1-.2% q N.meningitidis .025%
  • 23. Management q Mood swings q ED waiting time q Gut feeling q Guidelines q Clinical policies q Decision analysis q Algorithm q Resolution of conflicts in Freud’s second stage of development
  • 24. Clinical Guidelines in the Setting of Incomplete Evidence DAVID L. SCHRIGER ,Pediatrics, Volume 100 Number 1 July 1997 q “...the infectious disease experts who predominate the article by Baraff et al emphasize their experience with the rare child who does poorly; Kramer and Shapiro emphasize primary care practitioners' experience with the hundreds of children who do well…” q “...while most academic pediatric researchers have approached the febrile child as if there is only one opportunity to make the correct diagnosis and initiate treatment…” Kramer MS, Management of the febrile infant: a commentary on recent practice guidelines, Pediatrics;100;1;July 1997
  • 25. Clinical Policy for the Initial Approach to Children Under the Age of 2 Years Presenting with Fever Annals of Emergency Medicine Volume 22 Number 3 March 1993 q “...If the rules regarding admission appear too stringent at times, we remind our members that deviation from the rules requires only that the physician justify the deviation. In general, the rules are meant to protect the child…”
  • 26. A survey about management of febrile children without source by primary care physicians. Wittler RR - Pediatr Infect Dis J - 1998 Apr; 17(4): 271-7 q 1600 mailing list q GP, EP, Paeds q 3w, 7w, 4 mo, 16 mo, fever without source q Strong agreement to admit 3w and 7w q Outpatient ATB for 4 mo • GP 28%, Paeds 45%, EP 59% ¢¯ x3À of ceftriaxone since ‘91
  • 27. Pediatricians' Awareness of and Attitudes About Four Clinical Practice Guidelines Pediatrics Volume 101 Number 5 May 1998 q National survey, 300 respondants • 64% aware
  • 28. How about no treatment for OB q Persistent fever • 76% Vs 24% q Persistent bacteremia • 17% Vs 1,6% q Admitted • 50% Vs 12% q Cellulitis q Pneumonia q Meningitis • 2.7%-5.8% Vs 0.4%
  • 29. Serious bacterial infection q MENINGITIS • risk of OB 3% (85% pneumococcal) • risk of pneumococcal meningitis 3% • case fatality rate of 7,7% • 25-30% neurologic sequelae Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102:1087-1097. Pikis A, Kavaliotis J, Tsikoulas J, et al. Long-term sequelae of pneumococcal meningitis in children. Clin Pediatr. 1996;35:72-78.
  • 30. Treatment q Antibiotics ??? q Route ??? • Benzathine pen • PO • amoxil • IM • amoxil/clavulanic • IV acid • ceftriaxone
  • 31. Admission q Is it safe? Reassuring? q Iatrogenic and financial cost • nosocomial infections • iv infiltrates, fluid overload • drug toxicity • repeated testing, lost samples, contaminted samples, mislabeling • Stolen infant q There is no such thing as a short admission q Higher rates of admission if referred Iatrogenic risks and financial costs of hospitalizing febrile infants, DeAngelis C., AM J Dis Child;137;1146-1149;Dec 1983
  • 32. Pneumococcal vaccine q Capsular polysaccharide, major virulence factor q Conjugate, improved immunogenicity in young infants q Pneumococcal proteins • pneumolysin, pneumococcal surface protein A and pneumococcal surface adhesin A q Decreases colonisation as well as invasive infection q Replacement colonisation Rubin L.G, Pneumococcal vaccine, Pediatric Clinics of North America Volume 47 Number 2 April 2000
  • 33. Pneumococcal vaccine q Efficacy • meningitis • invasive disease • pneumonia q Schedule at 2,4,6,12,15 months
  • 34. Fever in the post- S.pneumoniae era q 95% HI-b invasive decrease 1987-1994 q Median age for bacterial meningitis • 1986 - 15 months • 1995 - 25 years Anne Schuchat, Bacterial meningitis in the US in 1995, N Engl J Med1997;337;970-6
  • 35. Who will you go with? q Ron Dagan q Rochester ,NY q Paul McCarhty q New Haven, Ct q Douglas Baker q Philadelphia, Pen q Baskin q Boston, Mass q Larry Baraff q Los Angeles,Ca q Nathan q Davis, Ca Kuppermann
  • 36. CONCLUSION q Adopt one line of conduct q Primum non-nocere q Elevate yourself beyond statistical numbers q Clinical judgment, medical common sens and decision making is what we trained for
  • 37. Definitions q Fever without a source (FWS) • No apparent etiology from history and physical examination q Fever of unknown origin (FUO) • No apparent etiology from history and physical examination lasting for at least 14 days q Serious bacterial infection (SBI) • Meningitis, bacteremia, pneumonia, uti, otitis,cellulitis,osteomyelitis
  • 38. Definitions q Occult bacteremia • presence of pathogenic bacterial organism in blood cultures of child with suspected infection

Hinweis der Redaktion

  1. Rectal temperature is long time recognised standard All other methods have prooved to be inconsistent and unreliable in peds Remember the poster with the infant’s blown out eyes because he is getting is rectal temparature taken????? No documented post-traumatic disorders related to rectal temperature taken … or maybe one
  2. Most of the fevers will have an identified source and will be treated accordingly.
  3. 6 items clinical scale to assess risk of SERIOUS ILLNESS 5points scale = normal 1, moderate impairment 3, severe impairment 5 scoring from 6 to 30 list of description found in sick kids interobservers agreement correlation validation by reapplying scale to their study group randomly divided in 2. 4 mo period nov 80-mar81 312 consecutive febrile child, &lt;24mo 165 with complete defined scale points, 16% serious illness INCLUDED CHILD WITH KNOW DISEASE Sensitivity 88% Specificity 77% PPV 56% NPV 95,3%
  4. In studies involving roughly 600 children, it was found that moderate or severe impairment on the YOS (score 10) had sensitivity of 83% to 88% specificity of 64% to 80% PPV of 48% to 56 NPV of roughly 97% . When the history, physical examination, and the YOS did not suggest serious illness, the probability of SBI being found was 1% to 4%. That chance increased to approximately 10% to 28% (seven- to tenfold) when either the history, physical, or YOS suggested serious illness. Other studies have shown that for YOS &gt;10, sensitivity = 5% PPV 5% but included sick child 12% rate of occult bacteremia.
  5. PPV of WBC is 8-15%, despite the fact that WBC&gt;15000 are more common in bacterial infection. Much lower, the less prevalent the disease (meningitis) A HIGH WBC DOES NOT = DISEASE!!!! CBC predictive values may vary with the pathogens involved Hx does not contribute to prediction of occult bacteremia Most occult bacteremias had fever for less than 24h Young boys with high fevers may be at higher risk RISK of occult bacteremia increases with temperature 39-39,4 1.2% 39,5-39,9 2,5% 40-40,4 3,2% &gt;40,5 4,4% WBC &lt;5 0 5-9,9 .3% 10-14,9 1.3% 15-19.9 4% &gt;20 8% ANC &gt;10 12%most sensitive and most accurate from ROC ABC &gt;1.5 5,2% BNR ANC, temp and age are the only sgnificant after adjusment for confounding variable
  6. Clinical and Lab criterias to assess risk of serious bacterial infection Predicts poorly who will be sick Fairly good to triage who will not be sick criterias based on previous reports all hospitalized infants &lt; 3mo; 39% &lt;30d; 41% 31-60d; 15 &gt;60d temp 38 233 144 low risk; 1 SBI; 89 high risk; 22 SBI; NPV for SBI 99,3% NPV for sepsis 100% 90% admission for benign disease
  7. It makes no clinical sens to order a CBC and Blood cultures. The latter obviates the need of the former.
  8. Knowing that since 1933, We had to start looking for the unknown
  9. Prevention of either death or serious morbidity is extremely rare. No testing other than U/A in certain situations. FOLLOW-UP
  10. The majority of kids do not have persistent bacteremia and so on. The data on meningitis comes from meta-analysis on the topic
  11. Conclusions are drawn over a very small number of outcomes, even if a large number of kids with fever enter the study. Analyzed over the wrong denominator, ie bacteremic as opposed to febrile. ANALYSE WHAT YOU RANDOMIZE
  12. 41/100 000 to 1,6/100 000, most cases in incomplete vaccination
  13. Kupperman: no test if Temp &lt;39.5 in 2-3 y or &lt;39 3-36mo, F/U 24h,risk&lt;1% CBC if Temp &gt;39.5 or 39 Approximately 76% of cases of occult pneumococcal bacteremia would be correctly identified by this strategy. For every 1000 febrile pediatric outpatients screened with an ANC, approximately 240 would have ANCs of 10 × 10 9 cells/L or more and therefore have blood cultures obtained and receive empiric antibiotics. Of these 240 patients, approximately 20 would have pneumococcal bacteremia, of whom approximately 1 would develop meningitis if not treated with empiric antibiotics. Shapiro: No test besides U/A,No ATB Baker: Temp&gt;38 + IOS&lt;10 + -ve full septic W/U, WBC AND BNR with easy follow-up, NPV 100%, with or without ATB Baskin: Like Baker, WBC 20 000 Baraff: 0-3MONTHS :Temp&lt;38-ve clinical criteria + WBC + ABC + BNR, urine culture, blood cultures, ± Ceftriaxone if LP 3-36 MONTHS and no Prevnar : Temp &lt;39.5, U/A +cultures if risks, WBC + ANC then blood cultures If +ve, Ceftriaxone anyways, CXR prn Dagan: Temp&gt;38, &lt;2Mo, home low risk with ± ATB pending cultures McCarthy: Nosuggestions for management
  14. The management of febrile pediatric patient will remain a clinical situation that calls for an educated guess of a patient’s risk for bacteremia based on the available data at hand Avoid double standards of treatment